CURRICULUM VITAE - Renata Schoemanrenataschoeman.co.za/wp-content/uploads/2014/07/RenataCV.pdf ·...
Transcript of CURRICULUM VITAE - Renata Schoemanrenataschoeman.co.za/wp-content/uploads/2014/07/RenataCV.pdf ·...
July 2014
1
CURRICULUM VITAE
PERSONAL DETAILS
Name: Renata Schoeman
CURRENT POSITION
2008+ Full time Private Practice
2011+ Researcher, Department of Chemical Pathology, University of Stellenbosch
2013+ MBA student, University of Stellenbosch Business School
2013+ Member of the USB-ED virtual faculty for Neuroleadership programmes
WORK EXPERIENCE
2000 Internship (Universitas/Pelonomi/National Complex)
2001 Community Service (Pelonomi/Botshabelo/Marokka Complex)
2002 Medical Officer (Dept Family Medicine, National Hospital, Bloemfontein)
2003-2006 Registrar Psychiatry (University of Stellenbosch, Dept of Health,
PAWC Lentegeur Hospital)
2007-2008 Research Fellow/Consultant (Dept of Psychiatry, University of
Stellenbosch
Extraordinary lecturer, Dept of Psychiatry, University of Stellenbosch
External lecturer, Neuroanatomy, Dept of Anatomy and Histology,
University of Stellenbosch
External lecturer, Clinical Neurology (Developed Clinical Neurology
curriculum for Speech and Language Therapists), Department of
Anatomy and Histology, University of Stellenbosch
Limited Private Practice
2008 Examiner: Colleges of Medicine of South Africa, Psychiatry (Part 1)
Examiner MMed Psychiatry Neurophysiology
July 2014
2
2009-2010 External lecturer, Department of Psychology, University of Stellenbosch
(Developed Brain Behaviour Module for Honors level students)
2009-2013 Sub-investigator Cape Trial Centre (Principal investigator: Juan
Schronen)
2009-2012 Member of the Health Research Ethics Committee, Faculty of Health
Sciences, University of Stellenbosch
QUALIFICATIONS
1993 Matriculated (C&N Secondary Girls’ School Oranje)
1999 MBChB (University of the Free State)
2001 BSocSc (Hons) (Psychology) (Cum Laude) (University of the Free State)
Diploma in Mental Health (SA) (Colleges of Medicine of South Africa)
Psychometrist registration examination, Professional Board of Psychology,
HPCSA
2002 MSocSc (Psychology) (University of the Free State)
2006 FCPsych (Colleges of Medicine of South Africa) (Cum Laude)
MMed (University of Stellenbosch) (Cum Laude)
2011 PhD
AWARDS
1993 Dux- pupil (C&N Secondary Girls’ School Oranje)
Image-builder of the year (C&N Secondary Girls’ School Oranje)
Best Cultural achievements (C&N Secondary Girls’ School Oranje)
Presidentsverkenner (‘Voortrekker’ Medal of Honour for exceptional
leadership)
Awards for “Best all-rounder” and “Best personal achievements” in “Die
Volksblad” and University of the Free State’s “Matriculant of the year”
1996-1999 Naspers-bursary
1997 JA Olivier- award for the best student in Forensic Medicine
July 2014
3
1998 Helmut Schimff- award for the best student in Othorhinolaringology
1999 Bristol- Myers Squibb- award for the student with the best achievement in
Psychiatry over all the years of study
2002 Awarded Academic Colours from the Student Council, University of the
Free State for exceptional achievement in the degree
BSocSc(Hons)(Psychology)
Awarded Dean’s medal for the best honours student in the Faculty of
Social Sciences, University of the Free State
Receives Kovsie Alumni Trust award as the best honours student in the
Faculty of Social Sciences, University of the Free State
Awarded National Research Foundation bursary
2005 Best Poster presentation by registrar, Neuroscience, Academic Year Day,
University of Stellenbosch
2006-2009 Thuthuka award, National Research Foundation
2007-2008 Medical Research Council Research Fellowship
2007-2008 Discovery Foundation Academic Fellowshiip
2007-2008 Harry Crossley Foundation Award
2007 Novartis medal for best results in Fellowship examination of the College of
Psychiatrists of South Africa, 2006
2008 Clinical Research Fellowship, Faculty of Health Sciences, University
Stellenbosch
American Psychiatric Association/AstraZeneca Young Minds in Psychiatry
Award, Washington, USA
Award for the best “Under 35 year” presentation in Neuroscience, Annual
Academic Yearday, Universtiy of Stellenbosch
2009 Included in the Marquis’ “Who’s who in the world”
2012 2nd price for Poster presentation, Neuroscience, Academic Year Day,
University of Stellenbosch
July 2014
4
COURSES/CONGRESSES ATTENDED
1994 South Sotho course (Bloemfontein Technical College)
2002 American Heart Association for the Basic Life Support for Healthcare
Providers Program (BLS)
American Heart Association for the Advanced Cardiovascular Life Support
Program (ACLS)
American Heart Association for the Pediatric Advanced Life Support
Program (PALS)
Co-presenter: Forensic Medicine and Pathology Refresher Course, for the
Department of Health, Eastern Cape
2004 Advanced Certificate in Electro Convulsive Therapy (South African
Society of Psychiatrists)
Narrative Therapy Workshop
Co-Presenter of Neurodevelopmental workshop, Dept Anatomy, University
Stellenbosch
Investigator Research Course (Foundation for Professional Development)
Evidence-based Practice and Cochrane Collaboration Workshop (SA
Cochrane Centre)
SASOP (South African Society of Psychiatrists) Congress
2005 Medical Ethics Course, Foundation for Professional Development (Cum
Laude)
CINP Congress
2006 South African Neuropsychology Association (SACNA) Congress
SASOP Congress
2007 Biological Psychiatry Congress, University of Stellenbosch
Workshop: Introduction to principles and processes of Research, University of
Stellenbosch
World Federation of Societies of Biological Psychiatry Congress, Chile
Training visit (Matrics Consensus Cognitive Battery, MGH, Boston, MA
Investigator Training Program (GCP), Phizer
July 2014
5
“Writing for Scientific Publication” workshop, Division of Research
Development, University of Stellenbosch
IRENSA (International Research Ethics in Southern Africa) Seminar
MGH/MIT/HMS AA Martinos Center for Biomedical Imaging Visiting
Fellowship Program, Boston, MA
2008 Training visit (Statistical Parametric Mapping) to Institute of Psychiatry, King’s
College, January 2008
APA Research Colloquium for Junior Investigators, May 2008, Washington,
USA
APA (American Psychiatric Organization) Congress, May 2008, Washinton,
USA
Fine Health Care Medical Workshop, Adult ADHD, Oct 2008, Cape Town,
RSA
Local Lundbeck Institute: Sharing Reponsibilities for Improved Care, Nov
2008, Johannesburg, RSA
Lundbeck Institute: Clinical trial meeting (Kopenhagen, Denmark)
2009 APA Congress, May 2009, San Francisco, USA
SASOP Biological Psychiatry Congress, May 2009, Kleinmond, South Africa
ECNP, September 2009, Istanbul, Turkey
2010 CINP Course in Psychopharmacology
ERECCA Good Clinical Practice course, University of Stellenbosch
Evidence-Based Psychiatry, Lundbeck Institute, Sept 2010, Johannesburg,
RSA
SASOP Neuropscyhiatry Symposium, August 2010, Cape Town, South Africa
2011 SASOP Psychiatry Symposium, March 2011, Cape Town, RSA
Lilly Neuroscience day, May 2011, Cape Town, RSA
Invited speaker, Lundbeck “Mad Hatter’s Tea Party”, June 2011, Cape Town,
South Africa
Invited speaker, CPC/Qualicare Open Day, July 2011, Cape Town, South
Africa
ECNP, September 2011, Paris, France
July 2014
6
Examiner’s workshop: Standard Setting, CMSA, Cape Town, South Africa
2012 CINP, June 2012, Stockholm, Sweden
Masterson’s Institute for Psychoanalytic Psychotherapy, August 2012, Cape
Town, South Africa
Tiny Handz (sign language)
2013 Invited speaker, Psychiatric Management Group, May 2013, Cape Town,
South Africa
Co-presenter, Neuroleadership, June 2013, Cape Town, South Africa
Invited speaker, Alzheimer’s South Africa, September 2013, Somerset West,
Cape Town, South Africa
ECNP, October 2013, Barcelona, Spain
ERECCA Good Clinical Practice course, University of Stellenbosch
2014 Co-presenter: Neuroscience of negotiation and mediation, USB-ED
Co-presenter: Neuroscience of managing differences, UCT-ED
PUBLICATIONS IN PEER REVIEWED JOURNALS
Schoeman R & Louw DA (2003). Neuropsychological Assessment versus Neuro-
imaging in the Diagnosis of Cerebral Lesions: An Explorative Study. Medical
Technology SA, 17(1), 386-393.
Louw DA & Schoeman R (2003). Moderator Variables in Neuropsychological
Assessment. Medical Technology SA, 17(2), 407-413.
Leppanen JM, Niehaus DJ, Koen L, Du Toit E, Schoeman R & Emsley R (2006).
Emotional face processing deficit in schizophrenia: a replication study in a South
African Xhosa Population. Schizophrenia Research, 84(2-3), 323-330.
Lochner C, Hemmings S, Seedat S, Kinnear C, Schoeman R, Annerbrink K, Olsson
M, Eriksson E, Moolman-Smook J, Allgulander C, Stein DJ. (2007). Genetics and
July 2014
7
personality traits in patients with social anxiety disorder: A case-control study in
South Africa. Eur Neuropsychopharmacol, 17(5), 321-327.
Leppanen JM, Niehaus DJ, Koen L, Du Toit E, Schoeman R & Emsley (2008).
Deficits in facial affect recognition in unaffected siblings of Xhosa schizophrenia
patients: Evidence for a neurocognitive endophenotype.
Schizophrenia Research. 99(1-3):270-3.
Emsley R, Chiliza B & Schoeman R. (2008). Predictors of long-term outcome in
schizophrenia. Curr Opin Psychiatry, 21(2):173-7.
Schoeman R, Southwood F, Chiliza B & Emsley R (2008). Bilingualism and
psychosis: a case report. Schizophrenia research, 103(1-3), 333-335.
Abubaker R, Alaerts M, Allman AA, Barnett J, Belujon P, Bittner RA, Burne TH, Cahn
W, Chance S, Cherkerzian S, Desouza R, Di Forti M, du Bois T, Fatjó-Vilas M,
Green M, Halpern D, John JP, Kemp A, Koelkebeck K, Lee J, Lodge DJ,
Michalopoulou P, Mompremier L, Nelson B, Perälä J, Rotarska-Jagiela A, Schoeman
R, Thakkar KN, Valuri G, Varambally S, Zai C, Delisi LE (2008). Summary of the 1st
Schizophrenia International Research Society Conference oral sessions, Venice,
Italy, June 21-25, 2008: The rapporteur reports. Schizophrenia Research. Oct;
105(1-3):289-383. Epub 2008 Sep 26
Leppanen JM, Niehaus DJ, Koen L, Schoeman R, Emsley R (2008). Allocation of
attention to the eye and mouth region of faces in schizophrenia patients. Cognitive
Neuropsychiatry, 13(6), 505-519.
Southwood F, Schoeman R & Emsley R (2009). Bilingualism and psychosis: A
linguistic analysis of a patient with differential symptom severity across languages.
Southern African Linguistics and Applied Language Studies, 27(2):163-171
July 2014
8
Schoeman R, Carey P, Seedat S (2009) Trauma and Posttraumatic Stress Disorder
in South African Adolescents: A case-control study of cognitive deficits. Journal of
Nervous and Mental Disease, 197(4):244-50.
Hoare J, Fouche J-P, Spottiswoode B, Joska JA, Schoeman R, Stein DJ & Carey PD
(2010). White matter correlates of apathy in HIV-positive subjects: a diffusion tensor
imaging study. J Neuropsychiatry Clin Neurosci, 22:313-320.
Schoeman R & Van der Merwe G (2010). Aphasia, an acquired language disorder.
SA Fam Pract, 52(4):308-311
Smit M, Conradie S & Schoeman R (2011). A grammatical analysis of the
spontaneous L2 English use of schizophrenic bilinguals compared to typical
bilinguals. Southern African Linguistics and Applied Language Studies, 29(4), 505-
513.
Theron J, Conradie S & Schoeman R (2011). Pragmatic assessment of
schizophrenic bilinguals' L1 and L2 use. Southern African Linguistics and Applied
Language Studies, 29(4):515-531.
Lachman A, Cloete KJ, Kidd M & Schoeman R (2012). The Clinical Utility and Cost
Effectiveness of Routine Thyroid Screening in Adult Psychiatric Patients Presenting
at Stikland Hospital, Cape Town, South Africa. African Journal of Psychiatry, 15:36-
41.
Delport, D, Schoeman R, Geiger, D & Kotza, M (2013). Significance of dietary folate
intake, homocysteine levels and MTHFR 677 C>T genotyping in South African
patients diagnosed with depression: Test development for clinical application
Metabolic Brain Disease. Neuroscience in Africa (in print).
July 2014
9
CHAPTERS
Schoeman R, Niehaus DJH, Koen L & Leppanen JM (2008) Emotion recognition
deficits as a neurocognitive marker of Schizophrenia liability. In MS Ritsner (Ed)
Neuropsychiatric Biomarkers, Endophenotypes, and Genes: Promises, advances,
and challenges. Springer (2009)
CONGRESS CONTRIBUTIONS/ PUBLIC PRESENTATIONS
Invited speaker at many different CME/CPD activities for psychiatrists, general
practitioners, allied health professionals, pharmacists, and also for the general
public.
Schoeman R, Lochner C, Moolman-Smook H, Hemmings S, Kinnear C,
Allgulander C, Seedat S & Stein D (2005). The Genetics of Social Anxiety
Disorder. Poster presentation at CINP Regional Meeting, Cape Town, RSA.
Schoeman R, Lochner C, Moolman-Smook H, Hemmings S, Kinnear C,
Allgulander C, Seedat S & Stein D (2005). The Genetics of Social Anxiety
Disorder. Poster presentation the International Anxiety Disorder Congress, Cape
Town, RSA
Schoeman R, Lochner C, Moolman-Smook H, Hemmings S, Kinnear C,
Allgulander C, Seedat S & Stein D (2005). The Genetics of Social Anxiety
Disorder. Best Poster presentation by registrar, Neuroscience, Academic Year
Day, University of Stellenbosch.
Schoeman R, Middleton T, Jordaan I, Carey P & Seedat S (2007).
Neuropsychological functioning in traumatised adolescents with and without
PTSD. Poster presentation at the Biological Psychiatry Congress, Cape Town,
RSA.
July 2014
10
Schoeman R, Middleton T, Jordaan I, Carey P & Seedat S (2007).
Neuropsychological functioning in traumatised adolescents with and without
PTSD. Poster presentation at the World Federation of Biological Psychiatry
Congress, Santiago de Chile
Schoeman R, Southwood F, Chiliza B & Emsley R (2007). Bilingualism and
Psychosis: a case report. Poster presentation at the Annual Academic Year Day,
University of Stellenbosch.
Schoeman R, Conradie S & Emsley R (2008). Differential expression of psychotic
features in late bilinguals: an fMRI study. Poster presentation at the American
Psychiatric Association Congress, Washington DC
Schoeman R, Chiliza B & Emsley R (2008). Early cognitive response to treatment in
First Episode Psychosis. Poster presentation at the American Psychiatric
Association Congress, Washington DC
Schoeman R, Conradie S & Emsley R (2008). Differential expression of psychotic
features in late bilinguals: an fMRI study. Oral presentation at the American
Psychiatric Association Research Colloquium for Junior Investigators, Washington
DC
Chiliza B, Schoeman R, Emsley R, Oosthuizen P, Niehaus D, Koen L & Hawkridge S
(2008). Treatment of first-episode psychosis: efficacy and tolerability of a long-acting
typical antipsychotic. Poster presentation at Schizophrenia International Research
Society Conference, Venice, Italy
Schoeman R, Southwood F, Chiliza B & Emsley R (2008). Bilingualism and
psychosis: a case report. Poster presentation at Schizophrenia International
Research Society Conference, Venice, Italy
July 2014
11
Schoeman R, Chiliza C, Emsley R (2008). Early cognitive response to treatment in
first episode psychosis. Poster presentation at Schizophrenia International Research
Society Conference, Venice, Italy
Focking M, Schoeman R, Dickers P, Hudson L, Dunn M & David R (2008).
Proteomic and Western blot analysis of hippocampal subregions in schizophrenia
and bipolar disorders. Poster presentation at Schizophrenia International Research
Society Conference, Venice, Italy
Chiliza B, Schoeman R, Emsley R, Oosthuizen P, Niehaus D, Koen L &
Hawkridge S (2008). Treatment of first-episode psychosis: efficacy and tolerability
of a long-acting typical antipsychotic. Poster presentation at Annual Academic
Year Day, Faculty of Health Sciences, University of Stellenbosch.
Du Toit, E, Niehaus DJH, Koen L, Schoeman R & Emsley R (2008). Emotional
face processing deficit in schizophrenia: a repliucation study in a South African
Xhosa population. Oral presentation at Annual Academic Year Day, Faculty of
Health Sciences, University of Stellenbosch.
Schoeman R, Conradie S & Emsley R (2008). Differential expression of psychotic
features in late bilinguals: an fMRI study. Poster presentation at Annual Academic
Year Day, Faculty of Health Sciences, University of Stellenbosch.
Schoeman R, Chiliza C, Emsley R (2008). Early cognitive response to treatment in
first episode psychosis. Oral presentation at Annual Academic Yearday, Faculty of
Health Sciences, University of Stellenbosch. Award for the best “Under 35”
presentation in Neuroscience.
July 2014
12
Schoeman R, Conradie S & Emsley R (2008). Differential expression of psychotic
features in late bilinguals: an fMRI study. Special lecture, Dept of Psychology,
University of Stellenbosch.
Schoeman R & Verster,C (2009). Selective Serotonin Reuptake Inhibitors: The effect
on Haemostasis (2009). Oral presentation at the SASOP Biological Psychiatry
Congress, Kleinmond, South Africa
Chiliza B, Schoeman R, Oosthuizen P, Koen L, Niehaus D, Emsley R.
Methamphetamine use and first episode psychosis in Cape Town. Oral presentation
at the South African Society of Psychiatrists Biological Psychiatry Congress, May
2009.
Chiliza B, Schoeman R, Oosthuizen P, Koen L, Niehaus D, Emsley R.
Characteristics of first episode psychosis patients with a history of
methamphetamine use. Poster presentation at the 10th Annual Meeting of the
International Society of Addiction Medicine, Cape Town, South Africa, November
2008.
Chiliza B, Schoeman R, Oosthuizen P, Koen L, Niehaus D, Hawkridge S, Emsley R.
Treatment of first-episode psychosis: efficacy and tolerability of a long-acting typical
antipsychotic. Poster presentation at the 6th International Conference on Early
Psychosis, Melbourne, Australia, October 2008.
Chiliza B, Schoeman R, Oosthuizen P, Koen L, Niehaus D, Hawkridge S, Emsley R.
Treatment of first-episode psychosis: efficacy and tolerability of a long-acting typical
antipsychotic. Oral presentation at the 15th National Congress of the South African
Society of Psychiatrists, August 2008.
Schoeman R, Oosthuizen P, Kidd M & Emsley R (2009). Social cogntion: Response
to treatment in first episode psychosis. ECNP, Turkey
July 2014
13
Conradie S & Schoeman R (2009). Linguistic analysis of schizophrenic speech in
bilinguals. LSSA, Cape Town
Davis W, de Kock L, Pretorius K, Schoeman R, van Rensburg SJ & Kotze MJ
(2011). Development of a single nucleotide polymorphism (SNP) knowledge
database: ASMT RS4446909, RSS598968 and MTHFR RS1801133 as susceptibility
alleles for depression. Biological Psychiatry Congress, Stellenbosch, South Africa.
Conradie S, Smit M, Theron J & Schoeman R (2012). Grammatical and pragmatic
analysis of the L1 and L2 use of schizophrenic bilinguals . International Second
Language Research Forum, Pittsburgh, USA
Schoeman R, Lachman A, Cloete KJ & Kidd M (2012). The clinical utility and cost
effectiveness of routine thyroid screening in adult psychiatric patients presenting
at Stikland Hospital, Cape Town, South Africa. Poster presentation at Annual
Academic Year Day, Faculty of Health Sciences, University of Stellenbosch.
Schoeman R, Lachman A, Cloete KJ & Kidd M (2013). The clinical utility and cost
effectiveness of routine thyroid screening in adult psychiatric patients presenting
at Stikland Hospital, Cape Town, South Africa. Poster presentation at European
College of Neuropsychopharmacology Congress, Barcelona, Spain.
RESEARCH EXPERIENCE
PhD: “A prospective study of cognitive deficits in First Episode Psychosis, and the
response thereof to treatment with Flupenthixol decanoate” (supervisor: Piet
Oosthuizen)
MMed thesis: “A Neuropsychological comparison between traumatized
adolescents with and without PTSD (supervisor: Soraya Seedat)
July 2014
14
MSocSc thesis: “Neuropsychological Assessment versus Neuro-imaging in the
Diagnosis of Cerebral Lesions” (supervisor: Dap Louw)
Investigator: Genes, metabolism, nutrition and depression with Susan Janse van
Rensburg and Marita Kotze (2011+)
Supervisor: M-student Medical Science (Darnielle Delport) “The development and
application of a polymerase chain reaction (PCR) based assay to determine the
impact of genetic variation in South African patients diagnosed with depression”
Investigator: Facial processing in Schizophrenia with Dana Niehaus et al (2008-
2009)
Investigator: Schizophrenia group with Robin Emsley et al (2007-2008)
Investigator: HIV neuropsychology with Paul Carey et al (2007-2009)
Investigator: Post traumatic stress disorder with Soraya Seedat et al (2004-2006)
Investigator: Social anxiety disorder genetics with Christene Lochner et al (2003-
2005)
Investigator: Differential expression of psychotic features in late bilinguals with
Simone Conradie et al (2008-2012)
Co-supervisor: M-student Linguistics (Tildie Smit) “A grammatical analysis of the
spontaneous language use of schizophrenic versus normal L2 speakers of
English”
Co-supervisor: M-student Linguistics (Janina Theron) “Pragmatic assessment of
schizophrenics' L1 and L2 use: A comparison of three assessment tools”
July 2014
15
Investigator: The use of Thyroid screening tests in Psychiatry (2008-2012)
Supervisor: MMed (Anusha Lachman) “The Clinical Utility and Cost Effectiveness
of Routine Thyroid Screening in Adult Psychiatric Patients Presenting at Stikland
Hospital, Cape Town, South Africa.
Investigator: Depression in brain tumours (2009-2011)
Supervisor: M-student Psychology (Winnie Janse van Rensburg) “The relationship
between depressive symptoms and post-operative subjective pain
perception after third molar surgery”
Investigator: Depression and the influence on acute post operative pain (2011+)
Supervisor: M-student Psychology (Carike Vermaak) in progress
CLINICAL TRIAL EXPERIENCE
N06/08/148: A prospective study of clinical, biological and functional aspects of outcome in
first-episode psychosis. (Phase IV). Designation: Sub-Investigator
M07/04/017: Acute effects of an atypical vs a conventional antipsychotic on brain structure
and function in first-episode psychosis: A voxel-based and functional MRI study. (Phase IV).
Designation: Sub-Investigator
ZM2005/00080/03: A Ten-Week multicenter randomized double blind placebo and active-
controlled parallel group flexible dose study evaluating the efficacy, safety and tolerability of
GSK372475 or Extended release Venlafaxine compared to placebo in adult subjects
diagnosed with Major Depressive Disorder. (Phase III). Designation: Sub-Investigator
D144AC00003: An International, Multicenter, Double-blind, Randomized, Placebo-
controlled, Phase IV Study of the Safety of Lithium versus Placebo as an add on to
July 2014
16
SEROQUEL XR™ (Quetiapine Fumarate) in Adult Patients with Acute Mania. Designation:
Sub-Investigator
H6P-MC-HDAY: A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and
Fluoxetine Combination versus Fluoxetine Only in the Relapse Prevention of Stabilized
Patients with Treatment-Resistant Depression. Designation: Sub-Investigator
3193A1-2005-WW: A 52-Week, 2-Period, Multicenter, Randomized, Double-Blind,
Donepezil-Referenced, Placebo-Controlled, Efficacy, and Safety Study of 3 Dosage Levels
of SAM-531 in Outpatients With Mild to Moderate Alzheimer’s Disease. Designation: Sub-
Investigator
3151A1-3360-WW: A Multicenter, Double-Blind, Placebo-Controlled, Randomized
Withdrawal, Parallel Group Study to Evaluate the Efficacy and Safety of 50mg/day of DVS
SR in Adult Outpatient’s With Major Depressive Disorder. Designation: Sub-Investigator
D1050235: A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose,
Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of
Bipolar I Depression. Designation: Sub-Investigator
D1050236: A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed Flexible-Dose,
Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression. Designation:
Sub-Investigator
D1050256: A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the
Treatment of Bipolar I Depression. Designation: Sub-Investigator
31-07-247: A 38-week, Multicenter, Randomized, Double-blind, Active-controlled Study to
Evaluate the Efficacy, Safety and Tolerability of an Intramuscular Depot formulation of
Aripiprazole (OPC-1457) as Maintenance Treatment in Patients with Schizophrenia “ASPIRE
EU” (Aripiprazole Intramuscular Depot Program in Schizophrenia) . Designation: Sub-
Investigator
31-07-248: A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of
Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients with Schizophrenia
July 2014
17
“ASPIRE OPEN-LABEL” (Aripiprazole Intramuscular Depot Program in Schizophrenia).
Designation: Sub-Investigator
R092670SCH3005: A 24-month, Prospective, Randomized, Active-Controlled, Open-Label,
Rater-Blinded, Multicenter, International Study of the Prevention of Relapse Comparing
Long-Acting Injectable Paliperidone Palmitate to Treatment as Usual with Oral
Antipsychotics Monotherapy in Adults With Schizophrenia. Designation: Sub-Investigator
RISSCH4230: This is an observational, non-interventional registry designed to assess
medication usage patterns and to explore, in clinical routine practice, long-term outcomes
and relevant factors for subject adherence to treatment, in subjects receiving antipsychotic
treatment with risperidone long-acting injectable (RLA) or oral antipsychotics. Six-month
retrospective data and 1-year prospective data will be collected. Designation: Sub-
Investigator
D144AC00003: An International, Multicenter, Double-blind, Randomized, Placebo controlled,
Phase IV Study of the Safety of Lithium versus Placebo as an add on to SEROQUEL XR™
(Quetiapine Fumarate) in Adult Patients with Acute Mania. Designation: Sub-Investigator
RGH-MD-05 11: A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficay of
Cariprazine in the Acute Exacerbation of Schizophrenia. RGH-MD-11 Open Label Extension
Study. Designation: Sub-Investigator
DFI5687: An Eight-Week, Multinational, Multicenter, Double-Blind, Active-And Placebo-
Controlled Clinical Trial Evaluating the Efficacy and Tolerability of Three Fixed Doses of
SSR125543 ( 20mg daily, 50mg Daily, and 100mg daily) in Outpatients with Major
Depressive Disorder. Designation: Sub-Investigator
D4130C00005: A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-
Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-
mecamylamine) as an Adjunct to an Antidepressant In Patients with Major Depressive
Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy. Designation:
Sub-Investigator
July 2014
18
F1J-MC-HMCK: A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in
the Treatment of Children and Adolescents with Major Depressive Disorder. Designation:
Sub-Investigator
P05896: An 8-week, Placebo-Controlled, Double-blind, Randomized, Fixed Dose Efficacy
and Safety Trial of Asenapine in Adolescent Subjects with Schizophrenia. Designation: Sub-
Investigator
P05897: A 26-week, Multi-Center, Open-Label, Flexible Dose, Long-term Safety Trial of
Asenapine in Adolescent Subjects with Schizophrenia. Designation: Sub-Investigator
R092670-SCA-3004: Phase 3b, A Randomized, Double-Blind, Placebo-Controlled, Parallel-
Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With
Schizoaffective Disorder. Designation: Sub-Investigator
H9P-MC-LNBM(b): A Randomized, Placebo-Controlled, Double-Blind Study of LY2216684
Fixed-Dose 12 mg and 18 mg Once Daily as Adjunctive Treatment for Patients With Major
Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Treatment. Designation: Sub-Investigator
D1050298: A Long-term, Multicenter, Open-Label, Flexible Dose Continuation Study in
Subjects Who Have Completed a Prior Lurasidone Study. Designation: Sub-Investigator
31-10-270: An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole
Intramuscular Depot in Patients with Schizophrenia. Designation: Sub-Investigator
F1J-MC-HMGI: A Double-Blind, Efficacy and Safety Study of Duloxetine versus Placebo in
the Treatment of Children and Adolescents with Generalized Anxiety Disorder. Designation:
Sub- Investigator
C10953/3072: A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to
Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/day) as
Adjunctive Therapy in Adults with Major Depression Associated with Bipolar I Disorder.
Designation: Sub -Investigator
July 2014
19
C10953/3073: A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to
Evaluate the Efficacy and Safety of Armodafinil Treatment (150mg/day) as Adjunctive
Therapy in Adults With Major Depression Associated With Bipolar I Disorder.
Designation: Sub-Investigator
C10953/3074: A 6-Month, Open-Label, Flexible-Dosage (150mg to 200mg/day) Extension
Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults
With Major Depression Associated With Bipolar I Disorder. Designation: Sub- Investigator
MEM-MD-91: An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric
Patients with Autism, Asperger’s Disorder, or Pervasive Developmental Disorder Not
Otherwise Specified (PDD-NOS). Designation: Sub-Investigator
MEM-MD-68: A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the
Safety and Efficacy of Memantine in Pediatric Patients with Autism, Asperger’s Disorder, or
Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated
with Memantine. Designation: Sub-Investigator
MEM-MD-69: An Open-Label Extension Study of the Safety and Tolerability of Memantine in
Pediatric Patients with Autism, Asperger’s, Disorder or Pervasive Developmental Disorder
Not Otherwise Specified (PDD-NOS). Designation: Sub-Investigator
SPD489-323: The SPD489-323 Phase 3, Multicenter, Randomized, Double-blind, Parallel-
group, Placebo-controlled, Flexible Dose Titration, Efficacy and Safety Study of SPD489 in
Combination with an Antidepressant in the Treatment of Adults with Major Depressive
Disorder with Inadequate Response to Prospective Treatment with an Antidepressant.
Designation: Study Coordinator
SPD489-329: A Phase 3, Open-label, Multicenter, 12-month Extension Safety and
Tolerability Study of SPD489 in Combination With an Antidepressant in the Treatment of
Adults With Major Depressive Disorder With Residual Symptoms or Inadequate Response
Following Treatment With an Antidepressant. Designation: Sub-Investigator
July 2014
20
CN162006: A Multicenter, Randomized, Double-Blind, Active-Controlled Study of the
Efficacy and Safety of Flexibly-Dosed BMS-820836 in patients with Treatment Resistant
Major Depression. Designation: Sub- Investigator
CN162010: A Multicenter, Double-Blind, 58 week Rollover Study to assess the Safety and
Tolerability of BMS-820836 in Patients with Treatment Resistant Major Depression.
Designation: Sub-Investigator
R092670PSY1005: Phase 1, A Single-Dose, Open-Label, Randomized, Parallel-Group
Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Paliperidone Palmitate
3-Month Formulation in Subjects with Schizophrenia. Designation: Sub- Investigator
D1050238: A Double-Blind, Placebo-Controlled, Randomized withdrawal Study of
Lurasidone for the Maintenance Treatment of Subjects with Schizophrenia. Designation:
Sub- Investigator
Ly450139: Protocol Amendment Summary H6L-MC-LFAN© Effect of γ-secretase Inhibition
on the Progression of Alzheimer’s Disease: LY450139 versus Placebo. Designation: Sub-
Investigator
CL2-38093-011: Efficacy and safety of S 38093 versus placebo in patients with mild to
moderate Alzheimer’s Disease. Designation: Sub-Investigator
PROFESSIONAL MEMBERSHIP
Health Professions Council of South Africa
South African Society of Psychiatrists
Psychiatric Management Group
South African Medical Association
Medical Protection Society
General Medical Council, UK
July 2014
21
PAST MEMBER (2007-2013)
American Psychiatric Association
World Federation of Biological Psychiatry
Schizophrenia International Research Society
Harp Society of South Africa
LEADERSHIP ACHIEVEMENTS
1993 Students Council, C&N Secondary Girls’ School Oranje
1994-1995 University of the Free State Central Rag Committee
1996 Students Council, Faculty of Medicine, Free State University
1997 Vice-chairperson, Student Council, Faculty of Medicine, Free State
University
2001-2002 Chairperson: Kosmos Garden Project, Psychiatric Complex of the
Free State
2002 Editor “Kosmonews” , Psychiatric Complex of the Free State
Infection Control Committee, Psychiatric Complex of the Free State